Annual SG&A
$20.62 M
-$6.69 M-24.50%
31 December 2023
Summary:
Applied Therapeutics annual selling, general & administrative expenses is currently $20.62 million, with the most recent change of -$6.69 million (-24.50%) on 31 December 2023. During the last 3 years, it has fallen by -$12.05 million (-36.89%). APLT annual SG&A is now -52.09% below its all-time high of $43.05 million, reached on 31 December 2021.APLT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$15.04 M
+$4.46 M+42.13%
30 September 2024
Summary:
Applied Therapeutics quarterly selling, general & administrative expenses is currently $15.04 million, with the most recent change of +$4.46 million (+42.13%) on 30 September 2024. Over the past year, it has increased by +$10.33 million (+219.26%). APLT quarterly SG&A is now at all-time high.APLT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.19 B
-$187.31 M-9.36%
30 September 2024
Summary:
Applied Therapeutics TTM selling, general & administrative expenses is currently -$2.19 billion, with the most recent change of -$187.31 million (-9.36%) on 30 September 2024. Over the past year, it has dropped by -$2.21 billion (-9843.40%). APLT TTM SG&A is now -10197.56% below its all-time high of $43.05 million, reached on 31 December 2021.APLT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.5% | +219.3% | -9843.4% |
| 3 y3 years | -36.9% | +38.8% | -5363.2% |
| 5 y5 years | +907.5% | +356.5% | -10000.0% |
APLT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.1% | at low | at high | +219.3% | -175.2% | at low |
| 5 y | 5 years | -52.1% | +907.5% | at high | +356.5% | -1477.0% | at low |
| alltime | all time | -52.1% | +3443.5% | at high | +3659.3% | <-9999.0% | at low |
Applied Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.04 M(+42.1%) | $39.72 M(+35.1%) |
| June 2024 | - | $10.58 M(+16.7%) | $29.39 M(+21.9%) |
| Mar 2024 | - | $9.07 M(+80.0%) | $24.11 M(+16.9%) |
| Dec 2023 | $20.62 M(-24.5%) | $5.04 M(+7.0%) | $20.62 M(-8.2%) |
| Sept 2023 | - | $4.71 M(-11.0%) | $22.47 M(-6.4%) |
| June 2023 | - | $5.29 M(-5.2%) | $24.00 M(-3.4%) |
| Mar 2023 | - | $5.58 M(-18.9%) | $24.83 M(-9.1%) |
| Dec 2022 | $27.32 M(-36.5%) | $6.88 M(+10.3%) | $27.32 M(-14.2%) |
| Sept 2022 | - | $6.24 M(+1.9%) | $31.83 M(-12.6%) |
| June 2022 | - | $6.13 M(-24.1%) | $36.42 M(-12.0%) |
| Mar 2022 | - | $8.07 M(-29.1%) | $41.37 M(-3.9%) |
| Dec 2021 | $43.05 M | $11.39 M(+5.1%) | $43.05 M(+3.5%) |
| Sept 2021 | - | $10.83 M(-2.2%) | $41.59 M(+2.0%) |
| June 2021 | - | $11.07 M(+13.6%) | $40.78 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $9.75 M(-1.8%) | $37.23 M(+13.9%) |
| Dec 2020 | $32.68 M(+147.0%) | $9.93 M(-0.9%) | $32.67 M(+22.6%) |
| Sept 2020 | - | $10.02 M(+33.2%) | $26.64 M(+33.8%) |
| June 2020 | - | $7.52 M(+44.8%) | $19.91 M(+20.1%) |
| Mar 2020 | - | $5.20 M(+33.2%) | $16.57 M(+25.2%) |
| Dec 2019 | $13.23 M(+546.4%) | $3.90 M(+18.4%) | $13.23 M(+32.8%) |
| Sept 2019 | - | $3.29 M(-21.3%) | $9.96 M(+37.1%) |
| June 2019 | - | $4.18 M(+125.5%) | $7.26 M(+108.6%) |
| Mar 2019 | - | $1.85 M(+194.9%) | $3.48 M(+70.1%) |
| Dec 2018 | $2.05 M(+251.7%) | $629.00 K(+5.2%) | $2.05 M(+44.4%) |
| Sept 2018 | - | $598.00 K(+49.5%) | $1.42 M(+72.9%) |
| June 2018 | - | $400.00 K(-4.8%) | $820.00 K(+95.2%) |
| Mar 2018 | - | $420.00 K | $420.00 K |
| Dec 2017 | $582.00 K | - | - |
FAQ
- What is Applied Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Applied Therapeutics?
- What is Applied Therapeutics annual SG&A year-on-year change?
- What is Applied Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Applied Therapeutics?
- What is Applied Therapeutics quarterly SG&A year-on-year change?
- What is Applied Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Applied Therapeutics?
- What is Applied Therapeutics TTM SG&A year-on-year change?
What is Applied Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of APLT is $20.62 M
What is the all time high annual SG&A for Applied Therapeutics?
Applied Therapeutics all-time high annual selling, general & administrative expenses is $43.05 M
What is Applied Therapeutics annual SG&A year-on-year change?
Over the past year, APLT annual selling, general & administrative expenses has changed by -$6.69 M (-24.50%)
What is Applied Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of APLT is $15.04 M
What is the all time high quarterly SG&A for Applied Therapeutics?
Applied Therapeutics all-time high quarterly selling, general & administrative expenses is $15.04 M
What is Applied Therapeutics quarterly SG&A year-on-year change?
Over the past year, APLT quarterly selling, general & administrative expenses has changed by +$10.33 M (+219.26%)
What is Applied Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of APLT is -$2.19 B
What is the all time high TTM SG&A for Applied Therapeutics?
Applied Therapeutics all-time high TTM selling, general & administrative expenses is $43.05 M
What is Applied Therapeutics TTM SG&A year-on-year change?
Over the past year, APLT TTM selling, general & administrative expenses has changed by -$2.21 B (-9843.40%)